Radiation Dermatitis
Radiation Dermatitis Market

Radiation dermatitis is a side effect of external beam ionizing radiation. It is also called radiodermatitis, x-ray dermatitis, radiation skin damage, or a radiation burn. Most commonly, radiation-induced dermatitis is caused by radiotherapy for underlying malignancies.


Radiation Dermatitis Epidemiological Segmentation 


The Epidemiological Segmentation of Radiation Dermatitis in 7MM from 2018 to 2030 is segmented into:-


  • Radiotherapy Utilization of Radiation Dermatitis
  • Incident cases of Radiation Dermatitis
  • Grade-specific cases of Radiation Dermatitis
  • Treated cases of Radiation Dermatitis


Radiation Dermatitis Epidemiological Insights Observed in 2020


  • The total incident population of Radiation Dermatitis in 7MM was found to be 3,012,048.
  • The United States had the largest Radiation Dermatitis incident population.
  • Among the EU5 countries, Germany had the highest incident cases of Radiation Dermatitis.
  • Spain had the lowest Radiation Dermatitis incident cases which were observed to be 151,518.


Radiation Dermatitis Market Insight


The Radiation Dermatitis therapeutic market is expected to increase at a CAGR of 14.62% in the 7MM during the study period (2018–2030).


Radiation Dermatitis Market Drivers


  • A huge population presents a massive market to any new entrant
  • Advances in radiation delivery technology


Radiation Dermatitis Market Barriers   

                 

  • Radiation leads to decreased quality of life as there is no standard in disease management
  • Limited prospective randomized data is available on the use of pharmacologic or supportive care agents, topical or non-topical, to prevent and treat the indication
  • The steady rise in alternatives for radiation therapy in the oncology space
  • Several off-label treatment options are currently available 


Radiation Dermatitis Emerging Drugs


The emerging drugs of the Radiation Dermatitis market are


  • Tempol (APC-400)
  • BMX-001, and others


Radiation Dermatitis Key Players


The key players working in the Radiation Dermatitis market are


  • Adamis Pharmaceuticals
  • Matrix Biomed
  • BioMimetix JV, and others